Dynamic heart rate response to multi-day unsupported ultra-endurance cycle racing: a case report.


Journal

Experimental physiology
ISSN: 1469-445X
Titre abrégé: Exp Physiol
Pays: England
ID NLM: 9002940

Informations de publication

Date de publication:
02 2019
Historique:
received: 29 08 2018
accepted: 12 12 2018
pubmed: 26 12 2018
medline: 1 8 2019
entrez: 25 12 2018
Statut: ppublish

Résumé

What is the main observation in this case? Ultra-endurance cycle racing is known to lead to suppressed heart rates as a product of time spent racing. This case report identifies a racer who experienced this phenomenon initially, but then uniquely experienced an overall increase in heart rate late in the race. What insight does it reveal? In this case, unique chronotropic disturbances to heart rate occurred as a result of the many extreme demands of ultra-endurance racing. Work should now focus on identifying the frequency of this response in other racers and whether the main causes are physiological, environmental or genetic in nature. Participation in ultra-endurance cycling events, such as the Transcontinental Race, is increasing. These extremely demanding races provide a unique opportunity for field observation of the limits of human endurance physiology and, importantly, when these limits might be exceeded and cross over into pathology. The heart is of special interest in this field, and previous data suggest that 'reverse drift' of heart rate occurs as a product of time and load in races of 24-48 h, whereas transient structural abnormalities have been observed upon completion of running ultramarathons. Here, we report a unique case of a male cyclist racing in the Transcontinental Race over an extended period of 14 days characterized by extreme workloads and a low quantity and quality of sleep. The heart rate response was dynamic over the course of the race and defined by a U-shaped quadratic relationship. A larger scale study is required to determine the relevance of this information to the ultra-endurance cycling community.

Identifiants

pubmed: 30582664
doi: 10.1113/EP087341
doi:

Types de publication

Case Reports

Langues

eng

Pagination

174-179

Informations de copyright

© 2018 The Authors. Experimental Physiology © 2018 The Physiological Society.

Auteurs

Daniel Brayson (D)

BHF Centre for Research Excellence, School of Cardiovascular Medicine and Science, King's College London, London, UK.

Alessandra Frigiola (A)

Guys and St Thomas' NHS Trust, St Thomas' Hospital, London, UK.

James E Clark (JE)

BHF Centre for Research Excellence, School of Cardiovascular Medicine and Science, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH